Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 331–340 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 331
- Medicine slug
- clorazepate
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 11
- Source count
- 11
- Agreement rate
- 1
- Recorded readings
40 to 50 hours
- Numeric value
- 40
- Unit
- hours
- Source records
- 11
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 11 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b59a3ab-3dff-4458-a63a-ef0d9e0d996d (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4b80e69-b7c7-471a-8ce8-4e992808c669 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40074ed8-0799-e3e0-e063-6394a90ad200 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:919cbd07-f587-4005-acff-26213dd1d1fb (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69451c35-dd9a-4690-8d5e-4dcfa8837620 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11b72861-64c9-4cdc-9289-c7fa9ea23bf6 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d592a27-f4cf-008a-e063-6394a90a2629 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:499a6989-8912-44b7-b1eb-ee8f85ae378f (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb5c9e98-02b2-4c36-b436-25b58fe3c7d5 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ccaf945-0369-3129-e063-6394a90a2740 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e07efe5-29b6-6d1e-661a-f696c4b17f43 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
Nordiazepam, the primary metabolite, quickly appears in the blood and is eliminated from the plasma with an apparent half-life of about 40 to 50 hours.
Projected row 332
- Medicine slug
- clorazepate
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 11
- Source count
- 11
- Agreement rate
- 1
- Recorded readings
97 to 98%
- Numeric value
- 97
- Unit
- %
- Source records
- 11
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 11 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b59a3ab-3dff-4458-a63a-ef0d9e0d996d (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4b80e69-b7c7-471a-8ce8-4e992808c669 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97-98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40074ed8-0799-e3e0-e063-6394a90ad200 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:919cbd07-f587-4005-acff-26213dd1d1fb (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97-98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69451c35-dd9a-4690-8d5e-4dcfa8837620 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11b72861-64c9-4cdc-9289-c7fa9ea23bf6 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d592a27-f4cf-008a-e063-6394a90a2629 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97-98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:499a6989-8912-44b7-b1eb-ee8f85ae378f (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb5c9e98-02b2-4c36-b436-25b58fe3c7d5 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ccaf945-0369-3129-e063-6394a90a2740 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e07efe5-29b6-6d1e-661a-f696c4b17f43 (opens source in a new tab)
Clorazepate label
Version not recorded · Effective date not recorded
The protein binding of nordiazepam in plasma is high (97 to 98%).
Projected row 333
- Medicine slug
- clozapine
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 16
- Source count
- 16
- Agreement rate
- 0.625
- Recorded readings
2.5 hours
- Numeric value
- 2.5
- Unit
- hours
- Source records
- 10
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 10 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5021d643-32d2-4167-b5d8-90870e68a787 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90876802-0e3a-44c9-9ff7-1754dfbe736a (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of CLOZARIL 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:883b5d43-0339-7dc1-f775-93791fb9b978 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine tablets 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d36c298b-7292-46e0-898f-43d3e11c3cf4 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9db7aefb-f607-4158-a310-181e631bc648 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7c748f8a-73ce-4bd3-aa30-9c66657f06ec (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25c0c6d5-f7b0-48e4-e054-00144ff8d46c (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine tablets 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fa59238-f0a6-4d00-9d8d-df2a43718fc1 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine tablets 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61fe53d5-ed5c-4e45-9189-709d08d386cb (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5c8a456-6f3c-4963-b321-4ed746f690e4 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of clozapine tablets 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing.
2.3 hours
- Numeric value
- 2.3
- Unit
- hours
- Source records
- 5
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 5 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:976be6e3-a9db-49c6-9b02-1ab168cf17b1 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following a dosage of 100 mg b.i.d., the average steady-state peak plasma concentration was 413 ng/mL (range: 132-854 ng/mL), occurring at the average of 2.3 hours (range: 1-6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09231d80-6343-4a34-bd5b-100c547fd3c9 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following a dosage of 100 mg twice daily, the average steady-state peak plasma concentration was 413 ng/mL (range: 132 to 854 ng/mL), occurring at the average of 2.3 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:caf2d4a6-2a23-4992-a807-560c4204afc4 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following a dosage of 100 mg twice daily, the average steady-state peak plasma concentration was 413 ng/mL (range: 132 to 854 ng/mL), occurring at the average of 2.3 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fccf4f7-2e30-4272-9800-225aaef20584 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following a dosage of 100 mg twice daily, the average steady-state peak plasma concentration was 413 ng/mL (range: 132 to 854 ng/mL), occurring at the average of 2.3 hours (range: 1 to 6 hours) after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ae4b8e4-d8b1-4f01-bb4c-cd1cea90b219 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following a dosage of 100 mg twice daily, the average steady-state peak plasma concentration was 413 ng/mL (range: 132 to 854 ng/mL), occurring at the average of 2.3 hours (range: 1 to 6 hours) after dosing.
2.2 hours
- Numeric value
- 2.2
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2592c9a8-fd74-4e0d-a895-b07b014cf355 (opens source in a new tab)
Clozapine label
Version not recorded · Effective date not recorded
Following oral administration of 100 mg to 800 mg VERSACLOZ, once daily, the average steady-state peak plasma concentration was 275 ng/mL (range: 105 - 723 ng/mL), occurring at the average of 2.2 hours (range: 1 - 3.5 hours) after dosing.
Projected row 334
- Medicine slug
- cocaine
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
3,877 ± 1,266 L
- Numeric value
- 3,877
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fb0298f-9756-26e8-e063-6294a90ae8f2 (opens source in a new tab)
Cocaine label
Version not recorded · Effective date not recorded
In studies with COCAINE HYDROCHLORIDE nasal solution, the apparent volume of distribution (Vd/F) of cocaine after intranasal administration is 3,877 ± 1,266 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f897764-fe30-090a-e063-6294a90af106 (opens source in a new tab)
Cocaine label
Version not recorded · Effective date not recorded
In studies with GOPRELTO, the apparent volume of distribution (Vd/F) of cocaine after intranasal administration is 3,877 ± 1,266 L.
Projected row 335
- Medicine slug
- codeine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
7%
- Numeric value
- 7
- Unit
- %
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5819bdf7-300e-45b8-8f3a-447b53656293 (opens source in a new tab)
Codeine label
Version not recorded · Effective date not recorded
Codeine has low plasma protein binding with about 7% to 25% of codeine bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:010905f9-3bcb-4b50-9fe8-a3ad0010f14c (opens source in a new tab)
Codeine label
Version not recorded · Effective date not recorded
Codeine has low plasma protein binding with about 7% to 25% of codeine bound to plasma proteins.
Projected row 336
- Medicine slug
- codeine
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
3 to 6 L/kg
- Numeric value
- 3
- Unit
- L/kg
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5819bdf7-300e-45b8-8f3a-447b53656293 (opens source in a new tab)
Codeine label
Version not recorded · Effective date not recorded
D i stribution: Codeine has been reported to have an apparent volume of distribution of approximately 3 to 6 L/kg, indicating extensive distribution of the drug into tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:010905f9-3bcb-4b50-9fe8-a3ad0010f14c (opens source in a new tab)
Codeine label
Version not recorded · Effective date not recorded
Distribution: Codeine has been reported to have an apparent volume of distribution of approximately 3 to 6 L/kg, indicating extensive distribution of the drug into tissues.
Projected row 337
- Medicine slug
- colchicine
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 51
- Source count
- 50
- Agreement rate
- 1
- Recorded readings
45%
- Numeric value
- 45
- Unit
- %
- Source records
- 50
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 50 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16d8e0f4-567d-4de1-ac25-6e2527f1d58e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d010a735-1a20-23fe-e053-2995a90abe0f (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8fd7034-5ca2-4a58-b303-7f78ffdf8d76 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df1dd89a-a1b3-48e8-b0e8-ad71b4cb0c96 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd93a40f-92ab-47ac-9083-b8a7a0b18ad6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee1583ac-c308-4beb-b602-9ecac4977026 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb509994-6ecc-4599-b87a-98495fef6129 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14d4be16-d355-4baf-b4cd-4d97d4b2dca0 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cb88c93-54b8-a548-e063-6294a90a94e6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:efe34b7c-0e6e-4aeb-9718-cf9b8e19a302 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ae87893-a065-468e-b8da-f1db86afcaef (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f69b9c6-8c00-45e2-b950-34dc5ae62352 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:467cd83f-d695-4040-9434-10e80b4271da (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
The absolute bioavailability of colchicine is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1ff526f-e89f-4dca-80b6-653d6bdfd895 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcf97364-b35f-4bc9-8a92-d3d2e05f47ac (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25307250-c16b-4467-9ad0-e6c752c576bd (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:472ec026-c755-ae02-e063-6394a90af0c6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b6abc78-b2d6-4949-b109-4c857f37ef12 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16d49c45-5b0a-a7fa-e063-6294a90a7320 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc0e205a-697e-d47e-e053-2995a90a154e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b414be4e-cd4f-4e7d-bbdd-b406c99c11b6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72984aa2-6df9-4460-9926-399ffed30e36 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4284783-fea6-4af2-9a8d-79c929176c05 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68d4bf2b-8e2c-4621-aa08-463f43e253c3 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cb5f9d85-6b81-49f8-bcd6-17b7bfbc10f2 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6adc880-5499-4691-93f3-27c87902d5fc (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11a62c34-db88-4a79-81a1-59b316d41d66 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b280f0dc-b24c-4606-aaf4-0673070d5b64 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94bee24f-d846-4344-bc42-b2eae6b433ba (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a15538ee-d1eb-4118-97c3-53748cea012a (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e5d9488-d9d0-4b37-b535-941d66c3430d (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7daef7e2-888d-4116-81a9-2c02b9ef97ef (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b78d6f7-714b-4e6c-b109-fbcb96d66633 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cefec2e-1982-4417-8d99-5711231b3933 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9111bbad-b020-44fb-b276-d7853e5acd2c (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f818ffe0-43df-4cc6-bc86-00b2c79b06fc (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5102af58-15b1-1516-e063-6294a90a50e3 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c7d013b7-0a67-0953-e053-2a95a90ac47c (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f5e24de-3956-4724-a5d7-fe81dcb07f6e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19486f52-1c7b-43b8-ba48-0d1a6389fedf (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c1ceff7-8f00-48cc-8ea4-678106455ff1 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac12e420-9f29-018e-e053-2a95a90ab612 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b310c57c-9192-4dc8-b76f-2c1982941caf (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e7ef16d-262b-4dc0-92d6-7afe4aa21ebd (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85acf34c-06c6-40ea-95f4-060d5de99277 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e7c8f65-4722-4187-9014-8fa81eb5681e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d83c6ae4-a41c-4b14-94b3-2d93c9aa28d1 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b79a786-3f9e-4dad-aa66-bae5f299b966 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cd5298e-43c6-a8dc-4467-9a3e1ade9307 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50b9c910-49a3-4a57-80f5-dc36c09da4df (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Absolute bioavailability is reported to be approximately 45%.
Projected row 338
- Medicine slug
- colchicine
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 51
- Source count
- 18
- Agreement rate
- 0.777778
- Recorded readings
31 h
- Numeric value
- 31
- Unit
- hours
- Source records
- 14
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 14 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee1583ac-c308-4beb-b602-9ecac4977026 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb509994-6ecc-4599-b87a-98495fef6129 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cb88c93-54b8-a548-e063-6294a90a94e6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:efe34b7c-0e6e-4aeb-9718-cf9b8e19a302 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:467cd83f-d695-4040-9434-10e80b4271da (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination The mean elimination half-life of GLOPERBA in healthy adults is 31 hours (± 6 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1ff526f-e89f-4dca-80b6-653d6bdfd895 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25307250-c16b-4467-9ad0-e6c752c576bd (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:472ec026-c755-ae02-e063-6394a90af0c6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16d49c45-5b0a-a7fa-e063-6294a90a7320 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cb5f9d85-6b81-49f8-bcd6-17b7bfbc10f2 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b280f0dc-b24c-4606-aaf4-0673070d5b64 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f5e24de-3956-4724-a5d7-fe81dcb07f6e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19486f52-1c7b-43b8-ba48-0d1a6389fedf (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d83c6ae4-a41c-4b14-94b3-2d93c9aa28d1 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Elimination half-life in humans was found to be 31 h (range 21.7 to 49.9 h).
18.8 hours
- Numeric value
- 18.8
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8fd7034-5ca2-4a58-b303-7f78ffdf8d76 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Patients with end-stage renal disease had 75% lower colchicine clearance (0.17 vs. 0.73 L/hr/kg) and prolonged plasma elimination half-life (18.8 hours vs. 4.4 hours) as compared to subjects with FMF and normal renal function [see Dosage and Administration ( 2.5 ), Use in Specific Populations ( 8.6 )] .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b6abc78-b2d6-4949-b109-4c857f37ef12 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Patients with end-stage renal disease had 75% lower colchicine clearance (0.17 vs. 0.73 L/hr/kg) and prolonged plasma elimination half-life (18.8 hours vs. 4.4 hours) as compared to subjects with FMF and normal renal function [see Dosage and Administration ( 2.5 ), Use in Specific Populations ( 8.6 )] .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6adc880-5499-4691-93f3-27c87902d5fc (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Patients with end-stage renal disease had 75% lower colchicine clearance (0.17 vs. 0.73 L/hr/kg) and prolonged plasma elimination half-life (18.8 hours vs. 4.4 hours) as compared to subjects with FMF and normal renal function [see Dose Modification in Renal Impairment (2.5) and Renal Impairment (8.6) ] .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94bee24f-d846-4344-bc42-b2eae6b433ba (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Patients with end-stage renal disease had 75% lower colchicine clearance (0.17 vs. 0.73 L/hr/kg) and prolonged plasma elimination half-life (18.8 hours vs. 4.4 hours) as compared to subjects with FMF and normal renal function [see Dosage and Administration ( 2.5 ), Use in Specific Populations ( 8.6 )] .
Projected row 339
- Medicine slug
- colchicine
- Compared field
- volumeOfDistribution
- Comparison state
- not_comparable
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- DENOMINATOR_MISMATCH
- Documents examined
- 51
- Source count
- 50
- Agreement rate
- 0.92
- Recorded readings
5 to 8 L/kg
- Numeric value
- 5
- Unit
- L/kg
- Source records
- 46
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 46 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16d8e0f4-567d-4de1-ac25-6e2527f1d58e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d010a735-1a20-23fe-e053-2995a90abe0f (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df1dd89a-a1b3-48e8-b0e8-ad71b4cb0c96 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd93a40f-92ab-47ac-9083-b8a7a0b18ad6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee1583ac-c308-4beb-b602-9ecac4977026 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb509994-6ecc-4599-b87a-98495fef6129 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14d4be16-d355-4baf-b4cd-4d97d4b2dca0 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cb88c93-54b8-a548-e063-6294a90a94e6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:efe34b7c-0e6e-4aeb-9718-cf9b8e19a302 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ae87893-a065-468e-b8da-f1db86afcaef (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f69b9c6-8c00-45e2-b950-34dc5ae62352 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1ff526f-e89f-4dca-80b6-653d6bdfd895 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcf97364-b35f-4bc9-8a92-d3d2e05f47ac (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25307250-c16b-4467-9ad0-e6c752c576bd (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:472ec026-c755-ae02-e063-6394a90af0c6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16d49c45-5b0a-a7fa-e063-6294a90a7320 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc0e205a-697e-d47e-e053-2995a90a154e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b414be4e-cd4f-4e7d-bbdd-b406c99c11b6 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72984aa2-6df9-4460-9926-399ffed30e36 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4284783-fea6-4af2-9a8d-79c929176c05 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68d4bf2b-8e2c-4621-aa08-463f43e253c3 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cb5f9d85-6b81-49f8-bcd6-17b7bfbc10f2 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6adc880-5499-4691-93f3-27c87902d5fc (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11a62c34-db88-4a79-81a1-59b316d41d66 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b280f0dc-b24c-4606-aaf4-0673070d5b64 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a15538ee-d1eb-4118-97c3-53748cea012a (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e5d9488-d9d0-4b37-b535-941d66c3430d (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7daef7e2-888d-4116-81a9-2c02b9ef97ef (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b78d6f7-714b-4e6c-b109-fbcb96d66633 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cefec2e-1982-4417-8d99-5711231b3933 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9111bbad-b020-44fb-b276-d7853e5acd2c (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f818ffe0-43df-4cc6-bc86-00b2c79b06fc (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5102af58-15b1-1516-e063-6294a90a50e3 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c7d013b7-0a67-0953-e053-2a95a90ac47c (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f5e24de-3956-4724-a5d7-fe81dcb07f6e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution: Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19486f52-1c7b-43b8-ba48-0d1a6389fedf (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c1ceff7-8f00-48cc-8ea4-678106455ff1 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac12e420-9f29-018e-e053-2a95a90ab612 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b310c57c-9192-4dc8-b76f-2c1982941caf (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e7ef16d-262b-4dc0-92d6-7afe4aa21ebd (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85acf34c-06c6-40ea-95f4-060d5de99277 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e7c8f65-4722-4187-9014-8fa81eb5681e (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d83c6ae4-a41c-4b14-94b3-2d93c9aa28d1 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution Colchicine has a mean apparent volume of distribution in healthy young volunteers of approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b79a786-3f9e-4dad-aa66-bae5f299b966 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cd5298e-43c6-a8dc-4467-9a3e1ade9307 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50b9c910-49a3-4a57-80f5-dc36c09da4df (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 to 8 L/kg.
5 L/kg
- Numeric value
- 5
- Unit
- L/kg
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8fd7034-5ca2-4a58-b303-7f78ffdf8d76 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 L/kg to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b6abc78-b2d6-4949-b109-4c857f37ef12 (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 L/kg to 8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94bee24f-d846-4344-bc42-b2eae6b433ba (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
Distribution The mean apparent volume of distribution in healthy young volunteers is approximately 5 L/kg to 8 L/kg.
1420 L
- Numeric value
- 1,420
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:467cd83f-d695-4040-9434-10e80b4271da (opens source in a new tab)
Colchicine label
Version not recorded · Effective date not recorded
h∙ng/mL) 19.90 (4.74) 18.47 (4.29) T max (h) (Min-Max) 1.00 (0.50: 2.00) 2.00 (1.00: 4.00) t 1/2 (h) 31.04 (5.99) 30.54 (5.22) Distribution The mean apparent volume of distribution (Vz/F) of GLOPERBA in healthy adults was approximately 1420 L.
Projected row 340
- Medicine slug
- colistimethate
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 6
- Source count
- 6
- Agreement rate
- 1
- Recorded readings
2 to 3 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 6
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 6 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:13dc3525-1879-4bd8-a922-81bc1397d5af (opens source in a new tab)
Colistimethate label
Version not recorded · Effective date not recorded
Serum concentration declined with a half-life of 2 to 3 hours following either intravenous or intramuscular administration in adults and in the pediatric population, including premature infants.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a335659-03b0-4a2d-9cd4-7dcf7da96fe6 (opens source in a new tab)
Colistimethate label
Version not recorded · Effective date not recorded
Serum concentration declined with a half-life of 2–3 hours following either intravenous or intramuscular administration in adults and in the pediatric population, including premature infants.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ec7dc90-825c-422e-9f4b-c8ace9d93af5 (opens source in a new tab)
Colistimethate label
Version not recorded · Effective date not recorded
Serum concentration declined with a half-life of 2 to 3 hours following either intravenous or intramuscular administration in adults and in the pediatric population, including premature infants.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d6e13e2-dc33-4b7b-84d0-66146a57c552 (opens source in a new tab)
Colistimethate label
Version not recorded · Effective date not recorded
Serum concentration declined with a half-life of 2–3 hours following either intravenous or intramuscular administration in adults and in the pediatric population, including premature infants.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab241809-0d2f-44ba-829c-26be67ee623f (opens source in a new tab)
Colistimethate label
Version not recorded · Effective date not recorded
Serum concentration declined with a half-life of 2 to 3 hours following either intravenous or intramuscular administration in adults and in the pediatric population, including premature infants.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf556f89-6373-45cb-b465-d991fde7eab9 (opens source in a new tab)
Colistimethate label
Version not recorded · Effective date not recorded
Serum concentration declined with a half-life of 2 to 3 hours following either intravenous or intramuscular administration in adults and in the pediatric population, including premature infants.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=330Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.